← All companies

BIVI

BioVie Inc.

BIVI Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.62

+0.10 +6.58%

Key statistics

from XBRL data in SEC filings

Market cap

$12.2M

Revenue (TTM)

—

Net income (TTM)

-$19.9M

EPS (TTM)

$-1.51

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$13.1M

Total assets

$17.5M

Gross margin

—

52-week range

$1.06 – $6.01

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 11, 2026 10-Q Quarter ended 2025-12-31 Feb 6, 2026 8-K Director or officer change Nov 13, 2025 8-K Shareholder vote results Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 10-K Fiscal year ended 2025-06-30 Aug 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 11, 2025 8-K Director or officer change; Regulation FD disclosure Jul 23, 2025 8-K Modified rights of security holders Jun 27, 2025 8-K Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Director or officer change Mar 28, 2025 10-Q Quarter ended 2024-12-31 Feb 11, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Shareholder vote results Nov 8, 2024 8-K Regulation FD disclosure; Other events Oct 29, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 29, 2024 8-K Regulation FD disclosure; Other events Oct 24, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 24, 2024 8-K Regulation FD disclosure; Other events Oct 22, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 22, 2024 10-K Fiscal year ended 2024-06-30 Sep 30, 2024 8-K Regulation FD disclosure; Other events Sep 25, 2024 8-K/A CURRENT REPORT AMENDMENT NO.1 Sep 24, 2024 8-K Entered a material agreement; Regulation FD disclosure Sep 24, 2024 8-K Other events Aug 21, 2024 8-K/A Modified rights of security holders; Amended charter or bylaws Aug 6, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Aug 1, 2024 8-K Director or officer change Jul 30, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Delisting notice or listing-rule failure Apr 19, 2024 8-K Other events Mar 11, 2024 8-K Regulation FD disclosure; Other events Mar 6, 2024 8-K/A CURRENT REPORT AMENDMENT NO.1 Mar 4, 2024 8-K Entered a material agreement; Regulation FD disclosure Mar 4, 2024 8-K Other events Mar 1, 2024 10-Q Quarter ended 2023-12-31 Feb 13, 2024 8-K Other events Jan 25, 2024 8-K Other events Jan 19, 2024 8-K Other events Nov 29, 2023